Fluminorex
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(RS)-5-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,3-oxazol-2-amine
|
|
Identifiers | |
CAS Number | 720-76-3 Y |
ATC code | none |
PubChem | CID: 24100 |
ChemSpider | 22530 Y |
UNII | LUO2Z7954T Y |
KEGG | D04210 Y |
ChEMBL | CHEMBL2107247 |
Chemical data | |
Formula | C10H9F3N2O |
Molecular mass | 230.19 g/mol |
|
|
|
|
(verify) |
Fluminorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
References
- ↑ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
<templatestyles src="Asbox/styles.css"></templatestyles>
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs not assigned an ATC code
- Drugs with no legal status
- Stimulants
- Oxazolidines
- Organofluorides
- Norepinephrine-dopamine releasing agents
- Oxazolines
- Nervous system drug stubs
Hidden category: